Want to see KR:101140 full AI Analyst Report?
INBIOGEN CO., Ltd. (101140) Income Statement
INBIOGEN CO., Ltd. Income Statement
Last quarter (Q2 2026), INBIOGEN CO., Ltd.'s total revenue was $1.51B, a decrease of 18.39% from the same quarter last year. In Q2, INBIOGEN CO., Ltd.'s net income was $-1.48B. See INBIOGEN CO., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 6.30B | $ 7.04B | $ 6.24B | $ 11.40B | $ 10.48B | |
| $ -574.39M | $ 660.07M | $ 1.28B | $ 2.56B | $ 1.96B | |
| $ 3.76B | $ 6.75B | $ 7.48B | $ 8.50B | $ 9.64B | |
| Depreciation and Amortization | $ 363.49M | $ 1.06B | $ 1.22B | $ 1.44B | $ 1.12B |
| $ -3.97B | $ 17.23B | $ 13.34B | $ 45.46B | $ 116.01B | |
| $ -4.33B | $ -6.09B | $ -6.15B | $ 44.02B | $ -7.69B | |
| $ 2.91B | $ 22.22B | $ 25.52B | $ -130.60B | $ 119.00B | |
| $ -1.42B | $ 16.12B | $ 19.37B | $ -136.64B | $ 111.06B | |
| $ 5.82B | $ 16.12B | $ 18.86B | $ -119.69B | $ 94.12B | |
| Per Share Metrics | |||||
| Basic EPS | $ 579.79 | $ 1614.68 | $ 1887.43 | $ -33008.46 | $ 1753.00 |
| Diluted EPS | $ 579.79 | $ 1614.68 | $ 1887.43 | $ -33008.46 | $ 1584.00 |
| Weighted Average Shares Outstanding | 10.04M | 9.98M | 9.99M | 3.63M | 2.97M |
| Weighted Average Shares Outstanding (Diluted) | 10.04M | 9.98M | 9.99M | 3.63M | 2.97M |
Currency in KRW